Σύγκριση μεθόδων

	Λειτουργικός Δείκτης Διαβίωσης-Καρκίνος (FLIC)	Λειτουργική Αξιολόγηση Θεραπείας Καρκίνου-Μαστού (FACT-B)
Πεδίο	Ογκολογική Νοσηλευτική	Ογκολογική Νοσηλευτική
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1984	1997
Δημιουργός	Henning Schipper	Marilyn Brady and David Cella
Τύπος	Patient self-report functional living and quality-of-life scale	Patient self-report disease-specific QoL instrument
Θεμελιώδης πηγή	Schipper, H., Clinch, J., & Olweny, C. L. M. (1996). Quality of life studies: definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 11–23). Lippincott-Raven.	Brady, M. J., Cella, D. F., Mo, F., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15(3), 974–986.
Εναλλακτικές ονομασίες	FLIC, Functional Living Index–Cancer	FACT-B, FACT-Breast
Συναφείς	4	4
Σύνοψη	The Functional Living Index-Cancer is a 22-item patient self-report instrument that measures health-related quality of life in cancer patients across physical, social, emotional, and overall QoL domains. Developed by Schipper and colleagues in the mid-1980s, the FLIC was among the first disease-specific QoL instruments for cancer and served as a foundational model for subsequent comprehensive measures like the EORTC QLQ-C30, bridging early generic QoL concepts with cancer-specific measurement.	The FACT-B is a comprehensive 36-item disease-specific quality-of-life instrument that integrates the generic FACT-G (27 items covering physical, social, emotional, and functional well-being) with a 9-item breast-cancer-specific subscale addressing body image, sexual function, arm symptoms, and treatment side effects. Developed by Brady et al. in 1997, the FACT-B is the gold-standard QoL measure for breast cancer research and clinical practice, used in hundreds of clinical trials and enabling comparison across breast cancer populations and treatment modalities.